Letter: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus ( 2019:43:711-7).
作者信息
Patoulias Dimitrios, Doumas Michael
机构信息
Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Veterans Affairs Medical Center, George Washington University, Washington, DC, USA.
出版信息
Diabetes Metab J. 2019 Dec;43(6):906-908. doi: 10.4093/dmj.2019.0107.
Abstract
摘要
相似文献
1
Letter: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus ( 2019:43:711-7).信函：达格列净对初治2型糖尿病患者内皮功能、肾损伤标志物及血糖控制的影响（2019年：43:711 - 7）
Diabetes Metab J. 2019 Dec;43(6):906-908. doi: 10.4093/dmj.2019.0107.
2
Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus ( 2019:43:711-7).回应：达格列净对初治2型糖尿病患者内皮功能、肾损伤标志物及血糖控制的影响（2019:43:711 - 7）
Diabetes Metab J. 2019 Dec;43(6):913-914. doi: 10.4093/dmj.2019.0149.
3
Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus.达格列净对初治2型糖尿病患者内皮功能、肾损伤标志物及血糖控制的影响
Diabetes Metab J. 2019 Oct;43(5):711-717. doi: 10.4093/dmj.2018.0208. Epub 2019 Mar 20.
4
Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).信函：达格列净治疗6个月对无动脉粥样硬化性心血管疾病的肥胖2型糖尿病患者代谢谱和内皮细胞功能障碍的影响（《肥胖与代谢综合征杂志》2020年；29：215 - 21）
J Obes Metab Syndr. 2021 Mar 30;30(1):72-73. doi: 10.7570/jomes20133.
5
Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).回应：达格列净治疗6个月对无动脉粥样硬化性心血管疾病的肥胖2型糖尿病患者代谢谱和内皮细胞功能障碍的影响（《肥胖与代谢综合征杂志》2020年；29:215 - 21）
J Obes Metab Syndr. 2021 Mar 30;30(1):74-75. doi: 10.7570/jomes21006.
6
Letter: genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population (diabetes metab j 2014;38:375-87).信函：全基因组关联研究在韩国人群中鉴定出两个对2型糖尿病和血糖性状具有性别特异性效应的新基因座（《糖尿病与代谢杂志》2014年；38:375 - 87）
Diabetes Metab J. 2014 Dec;38(6):484-6. doi: 10.4093/dmj.2014.38.6.484.
7
Letter: Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function ( 2019;43:840-53).信函：2型糖尿病且肾功能正常患者中颈动脉斑块的存在与肾功能快速下降相关（2019年；43卷：840 - 853页）
Diabetes Metab J. 2020 Feb;44(1):201-202. doi: 10.4093/dmj.2020.0017.
8
Letter: diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus (diabetes metab j 2013;37:262-9).信函：2型糖尿病患者的糖尿病视网膜病变与内皮功能障碍（《糖尿病代谢杂志》2013年；37卷：262 - 269页）
Diabetes Metab J. 2013 Oct;37(5):391-2. doi: 10.4093/dmj.2013.37.5.391.
9
Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7).信函：瑞巴派特对2型糖尿病患者胃肠道症状的影响（《糖尿病代谢杂志》2016年；40:240 - 247）
Diabetes Metab J. 2016 Aug;40(4):334-5. doi: 10.4093/dmj.2016.40.4.334.
10
Response: genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population (diabetes metab j 2014;38:375-87).回应：全基因组关联研究在韩国人群中发现了两个对2型糖尿病和血糖特征具有性别特异性影响的新基因座（《糖尿病与代谢杂志》2014年；38:375 - 87）。
Diabetes Metab J. 2014 Dec;38(6):487-8. doi: 10.4093/dmj.2014.38.6.487.
本文引用的文献
1
Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.比较不同代谢风险特征和低钠饮食个体沿葡萄糖连续谱的内皮功能和交感神经系统活性。
BMJ Open Diabetes Res Care. 2019 Mar 25;7(1):e000606. doi: 10.1136/bmjdrc-2018-000606. eCollection 2019.
2
Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus.达格列净对初治2型糖尿病患者内皮功能、肾损伤标志物及血糖控制的影响
Diabetes Metab J. 2019 Oct;43(5):711-717. doi: 10.4093/dmj.2018.0208. Epub 2019 Mar 20.
3
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.达格列净与 2 型糖尿病患者的心血管结局
N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.
4
The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.钠-葡萄糖协同转运蛋白2抑制剂达格列净显著改善未控制的2型糖尿病患者的外周微血管内皮功能。
Intern Med. 2018 Aug 1;57(15):2147-2156. doi: 10.2169/internalmedicine.0701-17. Epub 2018 Mar 30.
5
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study.达格列净急性改善 2 型糖尿病患者的内皮功能障碍，降低主动脉僵硬度和肾血管阻力指数：一项初步研究。
Cardiovasc Diabetol. 2017 Oct 23;16(1):138. doi: 10.1186/s12933-017-0621-8.
6
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.达格列净对早期 2 型糖尿病患者血管内皮功能和血糖控制的疗效：DEFENCE 研究。
Cardiovasc Diabetol. 2017 Jul 6;16(1):84. doi: 10.1186/s12933-017-0564-0.
7
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.钠-葡萄糖协同转运蛋白2抑制剂达格列净对微血管和大血管循环影响的随机研究
Cardiovasc Diabetol. 2017 Feb 23;16(1):26. doi: 10.1186/s12933-017-0510-1.
8
Aortic pulse wave velocity predicts incident cardiovascular events in patients with type 2 diabetes treated in primary care.主动脉脉搏波速度可预测基层医疗中接受治疗的2型糖尿病患者发生心血管事件的风险。
J Diabetes Complications. 2016 Sep-Oct;30(7):1223-8. doi: 10.1016/j.jdiacomp.2016.06.008. Epub 2016 Jun 19.
9
Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.内皮功能障碍在 2 型糖尿病患者心血管风险增加中起着关键作用：霍恩研究。
Hypertension. 2014 Dec;64(6):1299-305. doi: 10.1161/HYPERTENSIONAHA.114.04221. Epub 2014 Sep 15.
10
Endothelial dysfunction in type 2 diabetes mellitus.2型糖尿病中的内皮功能障碍。
Nutr Metab Cardiovasc Dis. 2006 Mar;16 Suppl 1:S39-45. doi: 10.1016/j.numecd.2005.10.015. Epub 2006 Feb 8.
Zotero 插件